Artificial Intelligence

Leidos' new $142M contract will use AI and Zero Trust to modernize secure information sharing for the U.S. military and intelligence community.

A new deal pairs Inturai's AI sensing platform with a firm of elite special forces veterans, aiming to revolutionize intelligence for North American forces.

The record $70 million sale of AI.com to Crypto.com's CEO signals a new era for digital assets, where a domain name can define an entire industry.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Bruker divisions unveil an open, AI-driven platform at SLAS2026, aiming to unify fragmented labs and enable 24/7 autonomous scientific discovery.

The race to power AI is on. Fermi America's massive private grid in Texas shows how new energy infrastructure is being built to bypass public grid limits.

The world's largest jewellery marketplace returns to Hong Kong, showcasing global innovation, from AI-driven design to new 'hard pure gold' craftsmanship.

The Middle East healthcare giant posts record profits and a $163M dividend, fueled by aggressive international acquisitions and a major bet on AI technology.

Facing a competitive market, Luotea appoints Hanna Inget as CCO to drive its 4-5% growth target by leveraging data, tech, and customer experience.

Zoya Technologies unveils an autonomous AI clinic that operates without the cloud, promising to revolutionize healthcare in underserved regions worldwide.

Leading Italian publisher adopts The Washington Post's Arc XP platform, betting on AI and data to navigate a radically changing media landscape.

With a new CEO from Visa-acquired Featurespace and fresh private equity backing, Ripjar is escalating its AI-driven battle against global financial crime.

Global giant CSL taps Swiss biotech Memo Therapeutics in a landmark deal, signaling a major shift from plasma to lab-grown immunotherapies.

Pulsar Helium's 100% success rate at its Topaz project hints at a vast new source of a rare isotope vital for national security and quantum computing.

Median Technologies' eyonis® LCS gains landmark FDA clearance, promising to revolutionize early detection of the deadliest cancer with its AI-powered diagnostics.

Johnson & Johnson unveils promising data for its next-gen AFib tech while reinforcing the safety of its current platform in a competitive market.

With record sales and millions of parcels shipped, Doorzo's 2025 success reveals a blueprint for cross-border e-commerce and surging global demand.

Riding a wave of record revenue, A10 Networks sets the stage for its Feb. 19 Investor Day, where it will detail its strategy for the AI infrastructure boom.

Forgent Power Solutions saw a strong NYSE debut, but with IPO funds paying back its PE owner, is this a growth story or a private equity cash-out?